ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
An Observational Study of Maternal Hypoglycemia in Pregnancy.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypoglycemia in pregnancy is relatively understudied, with conflicting evidence suggesting either outcomes similar to normal oral glucose tolerance test (OGTT) or associations with poor neonatal outcomes. Maternal glucose crosses the placenta, thus maternal hypoglycemia may affect the fetus. Objective: This study aimed to evaluate the association between maternal hypoglycemia and neonatal birth weight, specifically the risk of small-for-gestational-age (SGA) neonates, and to examine maternal metabolic outcomes in comparison to normoglycemic and hyperglycemic individuals. Study Design: This retrospective cohort study included 39,306 primiparous individuals aged 18-50 years. Participants were classified as hypoglycemic (glucose <70 mg/dL) hyperglycemic (≥1 abnormal OGTT value), or normoglycemic. The primary outcome was the rate of SGA (<10th percentile) and large-for-gestational-age (LGA, >90th percentile) neonates. Secondary outcomes included maternal hypertensive disorders, gestational diabetes requiring treatment (GDMA2), and long-term risk of diabetes mellitus (DM). Results: Among the cohort, 16,062 (40.9%) were hypoglycemic, 8543 (21.7%) were hyperglycemic, and 14,701 (37.4%) were normoglycemic. Compared to normoglycemic individuals, hypoglycemia was associated with an increased likelihood of SGA (OR 1.2, 95% CI 1.1-1.4), particularly in the second and third trimesters. Hyperglycemia was associated with an increased likelihood of LGA (OR 1.2, 95% CI 1.1-1.4). Hypoglycemia was also linked to a higher prevalence of gestational diabetes (GDMA2) and dysglycemia during pregnancy, yet a lower likelihood of developing DM later in life compared to hyperglycemic individuals. Conclusion: Maternal hypoglycemia during pregnancy is associated with an increased risk of SGA neonates and may serve as an early marker of underlying glucose dysregulation. Given these findings, repeated glucose monitoring and closer follow-up for individuals with hypoglycemia may be warranted. Future research should investigate long-term neonatal and maternal metabolic outcomes to refine clinical management strategies for hypoglycemia in pregnancy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.